mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |